4SC AG: 4SC announces Half-Year Report 2024 and provides update
Marketing Authorization Application (MAA) for resminostat (Kinselby) submitted to the European Medicines Agency (EMA…
Marketing Authorization Application (MAA) for resminostat (Kinselby) submitted to the European Medicines Agency (EMA…
Together with its partner Zelta by Merative, BSI Life Sciences announces the adoption of its Clinical Trial Management S…
Two new nominees will bring extensive technical operations expertise in the pharma and biotech industry, with broad and…
Swissmedic has granted Orphan Drug Status for resminostat for treatment of cutaneous T-cell lymphoma (CTCL) ODS benef…
TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel thera…
Twenty-five years ago, four young scientists registered the brand ibidi. Building on this foundation, they established t…
The Future Labs Live trade fair is one of the world's most diverse events in the fields of laboratories, start-ups, disr…
Biotechnology conference "BayOConnect" in Munich unites players from all areas of Bavarian and international biotechnolo…
Employment grows by 14% to 58,000 employees in the Bavarian biopharma sector Slight increase in the numbers of biop…
Pentixapharm AG, a clinical-stage biotech company discovering and developing novel targeted radiopharmaceuticals against…